Evidence map›Paper›PMID 31949863›Full record

ArticleInternational journal of clinical and experimental pathology2018

Copy number variation in progression of inverted papilloma to squamous cell carcinoma of the nasal cavity.

Dong Hoon Shin, Jong-Kil Lee, Kyu-Sup Cho, Hwan-Jung Roh

Open access · greenAbstract read
In one paragraph

Article in International journal of clinical and experimental pathology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
–field-weighted citation impact, top 66% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it, 2 citations in OpenAlex.

  1. Pooled it
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Dong Hoon ShinDepartment of Pathology, Pusan National University Yangsan Hospital Yangsan, Republic of Korea.
Jong-Kil LeeDepartment of Otorhinolaryngology and Research Institute for Convergence of Biomedical Science and Technology, Pusan National University Yangsan Hospital Yangsan, Republic of Korea.
Kyu-Sup ChoDepartment of Otorhinolaryngology and Biomedical Research Institute, Pusan National University Hospital Busan, Republic of Korea.
Hwan-Jung RohDepartment of Otorhinolaryngology and Research Institute for Convergence of Biomedical Science and Technology, Pusan National University Yangsan Hospital Yangsan, Republic of Korea.
Pusan National University Yangsan Hospital · KRPusan National University Hospital · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Inverted papilloma (IP) is a benign tumor occurring in nasal cavity. It can recur or progress to squamous cell carcinoma (SCC). The molecular mechanism of their biologic behavior is not fully revealed. Copy number variation (CNV) may contribute to progression of IP. We performed microarray comparative genome hybridization (aCGH). Five cases of IP, 2 cases of IP with dysplasia, 7 cases of SCC arising in a background of IP were submitted. The average numbers of somatic CNVs and copy number variable regions (CNVRs) were 991.9 and 866.9, respectively. Gain of 19p13.3, including 30 protein-coding genes, was observed in 2 IP and 7 SCC cases. Among those genes, BSG encoding the extracellular matrix metalloproteinase (MMP) inducer (EMMPRIN)/CD147 may play more important role in the progression of IP to SCC. Further study for validation of the aCGH result is necessary.

Indexed as

inverted papillomaNasal cavitysquamous cell carcinoma

Identifiers

PMID31949863
PMCPMC6962980
OpenAlexW3004437157

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.